Dissolution & Release Testing Method Validation

Regulatory Expectations for Dissolution Method Validation in ANDA Submissions

Regulatory Expectations for Dissolution Method Validation in ANDA Submissions Dissolution validation for ANDA (Abbreviated New Drug Application) submissions is a critical aspect of pharmaceutical manufacturing, particularly within the framework of regulatory compliance. Regulatory authorities, including the US FDA, EMA, and others, provide comprehensive guidelines on the validation of dissolution methods, ensuring that generic drugs demonstrate therapeutic equivalence to their branded…

Continue Reading Regulatory Expectations for Dissolution Method Validation in ANDA Submissions

Investigations of OOS Dissolution Results Linked to Weak Method Validation

Investigations of OOS Dissolution Results Linked to Weak Method Validation Investigations of OOS Dissolution Results Linked to Weak Method Validation In the pharmaceutical industry, the assurance of product quality is paramount, especially when it comes to analytical methods used in quality control (QC). Among these, the dissolution test is vital for ensuring that a drug product meets its specifications. However,…

Continue Reading Investigations of OOS Dissolution Results Linked to Weak Method Validation

Handling Surfactants and Complex Media in Dissolution Method Validation

Handling Surfactants and Complex Media in Dissolution Method Validation The validation of analytical methods in pharmaceutical development is critical for ensuring the quality and efficacy of drug products. One of the often-challenging aspects of this validation is the introduction of surfactants and complex media into dissolution testing. This article provides professionals in the pharmaceutical industry with a comprehensive step-by-step tutorial…

Continue Reading Handling Surfactants and Complex Media in Dissolution Method Validation

Dissolution Method Validation for Fixed-Dose Combination Products

Dissolution Method Validation for Fixed-Dose Combination Products Dissolution Method Validation for Fixed-Dose Combination Products Introduction to Validation in Pharmaceutical Development The validation of analytical methods, particularly in the context of dissolution testing, plays a vital role in the pharmaceutical industry. The US FDA, EMA, and other regulatory authorities have established stringent guidelines to ensure that products are consistently manufactured to…

Continue Reading Dissolution Method Validation for Fixed-Dose Combination Products

Lifecycle Management and Periodic Review of Dissolution and Release Methods

Lifecycle Management and Periodic Review of Dissolution and Release Methods The validation of analytical methods is a fundamental requirement for the pharmaceutical industry, ensuring that products are safe, effective and manufactured to the highest quality. In particular, the lifecycle management of dissolution and release testing methods plays a critical role in the overall validation process. This article provides a comprehensive…

Continue Reading Lifecycle Management and Periodic Review of Dissolution and Release Methods

Global Harmonisation of Dissolution Method Validation Across US, EU and UK Sites

Global Harmonisation of Dissolution Method Validation Across US, EU and UK Sites Global Harmonisation of Dissolution Method Validation Across US, EU and UK Sites Understanding Dissolution Method Validation Dissolution method validation is a crucial component of pharmaceutical development and quality control processes. It ensures that the dissolution testing method accurately reflects the performance of a drug product in vivo. Regulatory…

Continue Reading Global Harmonisation of Dissolution Method Validation Across US, EU and UK Sites

Use of USP and EMA Guidance in Designing Dissolution Method Validation Protocols

Use of USP and EMA Guidance in Designing Dissolution Method Validation Protocols Use of USP and EMA Guidance in Designing Dissolution Method Validation Protocols In the realm of pharmaceutical manufacturing, ensuring the quality and efficacy of drug products is paramount. Dissolution testing plays a crucial role in this quality assurance process. With evolving regulatory expectations from the FDA, the EMA,…

Continue Reading Use of USP and EMA Guidance in Designing Dissolution Method Validation Protocols

Validating In Vitro Release Tests for Semi-Solid and Transdermal Products

Validating In Vitro Release Tests for Semi-Solid and Transdermal Products Validating In Vitro Release Tests for Semi-Solid and Transdermal Products The validation of in vitro release tests (IVRT) and in vitro permeation tests (IVPT) for semi-solid and transdermal products is a critical component in the pharmaceutical quality assurance framework. This article delineates the regulatory expectations outlined by various authoritative bodies,…

Continue Reading Validating In Vitro Release Tests for Semi-Solid and Transdermal Products

Inspection-Ready Dissolution Method Validation Reports for FDA and EMA

Inspection-Ready Dissolution Method Validation Reports for FDA and EMA Introduction to Dissolution Method Validation Dissolution method validation is a critical process in the pharmaceutical industry, ensuring that products meet regulatory expectations for quality and reproducibility. This guide provides an in-depth, step-by-step tutorial on creating inspection-ready dissolution validation reporting, which is crucial for submissions to regulatory authorities, including the FDA and…

Continue Reading Inspection-Ready Dissolution Method Validation Reports for FDA and EMA